ELLXF - Elixinol Global Limited

Other OTC - Other OTC Delayed Price. Currency in USD
+0.0300 (+1.19%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close2.5200
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Avg. Volume390,175
Market Cap309.086M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.38
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire14 days ago

    Elixinol Global Significantly Expands European Operations

    OTCQX: ELLXF), has expanded its EU operations with key personnel hires and offices in the Netherlands, Spain, and the United Kingdom. The appointments are accompanied by a new go-to-market strategy and key initiatives including the launch of new e-commerce capabilities, sales hubs, with 12 full-time sales and marketing employees, in the Netherlands, Spain, and the United Kingdom aimed at capturing the European cannabis market opportunity, which analysts expect will be worth more than $130 billion in annual sales by 2028 (in today’s dollars).

  • GlobeNewswire14 days ago

    Streetwise Reports Examines Elixinol; Is It the Fastest Growing Hemp/CBD Producer?

    SAN FRANCISCO, Feb. 05, 2019 -- Fincom Investment Partners discusses Elixinol Global Ltd.'s (EXL:ASX; ELLXF:OTCQX)  Q4 earnings, and the hemp/CBD field. Company mentioned:.

  • GlobeNewswire27 days ago

    Global Hemp CBD Brand Elixinol Launches in New Zealand

    Leading global hemp CBD company Elixinol, has announced its entry into the New Zealand marketplace, offering its comprehensive range of cannabidiol (CBD) products to the NZ public on a prescription basis via the elixinol.com website. OTCQX: ELLXF) and has launched in New Zealand following the December 2018 passage of New Zealand’s Misuse of Drugs (Medicinal Cannabis) Amendment Act.

  • GlobeNewswire27 days ago

    Global CBD Brand Elixinol Announces Entry Into New Zealand Marketplace

    The announcement comes on the heels of the December 2018 passage of New Zealand’s Misuse of Drugs (Medicinal Cannabis) Amendment Act which classifies CBD, with low levels of THC as prescription medicine and removes CBD as a Class B1 controlled drug. Individual patients may now import up to a 3-month supply of CBD products, provided those products meet prescription medicine guidelines. Medicinal practitioners, pharmacies may also import and sell CBD products as can individuals or companies holding a license to sell medicines in New Zealand.

  • GlobeNewswire2 months ago

    Elixinol Welcomes Hemp Industry Advocate Joy Beckerman As Regulatory Officer & Industry Liaison

    OTC: ELLXF), announces Joy Beckerman’s appointment to Elixinol’s team starting January 1, 2019. In Beckerman’s role as Regulatory Officer and Industry Liaison, she will advise Elixinol’s executive team on the industry’s changes and ensure Elixinol’s practices continue to meet or exceed the requirements of hemp’s dynamic regulatory framework following the 2018 Farm Bill which federally legalized hemp.

  • One of the largest CBD company’s CEO is stealthily backing a hemp plastics startup
    Yahoo Finance2 months ago

    One of the largest CBD company’s CEO is stealthily backing a hemp plastics startup

    Paul Benhaim launched one of the most successful CBD companies in the world, but he's putting some of the riches from that venture back into hemp plastics — a bygone dream made possible by the farm bill.

  • GlobeNewswire2 months ago

    Streetwise Reports Examines 15 Reasons Why Hemp Producer Elixinol Should Be in Your Portfolio

    SAN FRANCISCO, Dec. 18, 2018 -- The U.S. Congress passed the 2018 Farm Bill that legalizes hemp; the bill is expected to be signed by the President soon. Against this backdrop,.

  • TheStreet.com2 months ago

    Farm Bill Passes, and These Hemp Companies Will Be Big Winners

    The 2018 Farm Bill was passed by the Senate on Tuesday by a vote of 87-13. The next move is that the legislation heads to the House for a vote -- and then if it passes there, it goes to President Trump to be signed into law. The impact of this legislation on the cannabis industry is enormous.

  • GlobeNewswire2 months ago

    Elixinol Welcomes U.S. Launch of Indulgent Hemp-Based Natural Skin Care

    DENVER, Dec. 11, 2018 -- US-based Elixinol announces the distribution of its first globally available, all-natural, hemp-based skin care and hair care line, Sativa. The 8.

  • ACCESSWIRE2 months ago

    Elixinol Global is Growing the Top Line Driven by Elixinol and Expanding Operations

    NEW YORK, NY / ACCESSWIRE / December 11, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Elixinol Global Limited (ELLXF), a global presence in the cannabis industry including hemp-derived CBD dietary supplements, food and wellness products, as well as the cultivation and manufacture of medicinal cannabis products. The Company is closely monitoring ongoing 2018 Farm Bill legislative changes in the US which, if passed will strengthen the Elixinol USA business considerably and open up its ability to trade nationally and accelerate growth. The management expects growth in the Hemp Foods Australia business to be supported by launches of the company's own finished food products and penetration in the cosmetics segment through its SATIVA Skincare range.

  • Benzinga3 months ago

    As Congress Bickers Over Farm Bill, MariMed Gets Internationally Busy Down Under

    As the industry impatiently awaits passage of the 2018 Farm Bill and pending removal of hemp from the Controlled Substances Act, companies are quickly moving to position themselves as leading suppliers of hemp-based CBD products, and investors are all too happy to help foot the bill. Two companies that have been particularly aggressive in their pursuit of the hemp-based CBD market have been Elixinol Global Ltd. (OTCQX: ELLXF) and MariMed, Inc. (OTCQB:MRMD). Shares for the IPO were sold at $1.00 AUD per share ($0.73 USD), but the stock quickly climbed to $1.82 AUD ($1.32 USD) within the first week of trading.

  • OTC Markets Group Welcomes Elixinol Global Limited to OTCQX
    PR Newswire5 months ago

    OTC Markets Group Welcomes Elixinol Global Limited to OTCQX

    NEW YORK , Sept. 18, 2018 /PRNewswire/ --  OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Elixinol Global Limited (ASX: EXL; ...

  • Financially Sounds Stocks Poised For High Growth
    Simply Wall St.10 months ago

    Financially Sounds Stocks Poised For High Growth

    Catapult Group International is one of many stocks the market is bullish on. Its expected double-digit top-line and bottom-line growth exceeds its peers, and its financially stable position lessens theRead More...